Category: Clinical trials

Tetraphase Announces Positive Top-line Results from Phase 3 IGNITE 1 Clinical Trial of Eravacycline in Complicated Intra-abdominal Infections

WATERTOWN, Mass., December 17, 2014--(BUSINESS WIRE)-- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today...

Lilly And Incyte Announce Positive Top-Line Results From Phase 3 Trial Of Baricitinib In Moderate To Severe Rheumatoid Arthritis

INDIANAPOLIS, Dec. 9, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announce that the Phase 3 RA-BEACON study of the investigational medicine baricitinib met its primary endpoint of improved ACR20...

New Data Show Idarucizumab Reverses Anticoagulant Effects of Dabigatran in Middle-Aged, Elderly and Renally Impaired Volunteers

Ridgefield, CT, December 8, 2014 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced phase I data that showed administration of investigational idarucizumab in healthy volunteers who were middle-aged (45 to 64 years) or elderly (65 to 80...

Takeda Presents Phase 2 Data on Maintenance with Single-Agent Investigational Ixazomib in Patients with Newly Diagnosed Multiple Myeloma

San Francisco, CA, December 7, 2014 and Osaka, Japan, December 8, 2014 – Takeda Pharmaceutical Company Limited (TSE:4502) today announced results from an open-label, Phase 2 study evaluating the safety and efficacy of oral, single-agent ixazomib...

Novartis Highlights New CTL019 Clinical Data Showing Complete Remissions in Relapsed/Refractory Acute Lymphoblastic Leukemia

EAST HANOVER, N.J., Dec. 6, 2014 Findings from continued clinical studies of investigational chimeric antigen receptor (CAR) therapy, CTL019, demonstrate its potential role in the treatment of certain types of lymphocytic leukemia. In one long-term...